We use cookies to customise content for your subscription and for analytics.
If you continue to browse Lexology, we will assume that you are happy to receive all our cookies. For further information please read our Cookie Policy.

Search results

Order by: most recent most popular relevance



Results: 1-10 of 204

California’s OEHHA Issues Final Proposition 65 “Clear and Reasonable Warning” Regulations
  • Sidley Austin LLP
  • USA
  • September 12 2016

On August 30, 2016, California’s Office of Environmental Health Hazard Assessment (OEHHA) released final amendments to the Proposition 65 warning


New genetically engineered foods disclosure law enacted
  • Sidley Austin LLP
  • European Union, USA
  • August 10 2016

On July 29 2016 President Obama signed into law S764, which mandates the establishment of federal disclosure standards applicable to "bioengineered"


Hong Kong Introduces New Labeling Requirements for Follow-up Formula and Packaged Food for Infants and Young Children
  • Sidley Austin LLP
  • Hong Kong
  • July 7 2016

Hong Kong has amended its food and drugs (composition and labeling) regulations (the Regulations) to introduce mandatory requirements for nutrition


EU Institutions Agree on Overhaul of Medical Device and IVD Rules
  • Sidley Austin LLP
  • European Union
  • June 23 2016

On June 15, 2016, the European Council's Permanent Representatives Committee and the European Parliament's Environmental Committee, supported by the


FDA Overhauls Design and Content of Nutrition Labeling
  • Sidley Austin LLP
  • USA
  • May 26 2016

On May 20, 2016, the Food and Drug Administration (FDA) announced the release of two final rules amending its nutrition labeling regulations. The


FDA Issues Draft Guidance on Additive Manufactured Devices
  • Sidley Austin LLP
  • USA
  • May 19 2016

On May 10, the U.S. Food and Drug Administration (FDA) issued draft guidance to provide its initial thoughts on regulatory requirements for additive


FDA's Final Medical Foods Guidance Maintains Restrictions on Category
  • Sidley Austin LLP
  • USA
  • May 16 2016

On May 12, 2016, the Food and Drug Administration (FDA) finalized its August 2013 Draft Guidance, "Frequently Asked Questions About Medical Foods


Significant Changes by the VA in Country of Origin Requirements for Federal Supply Schedule Contracts
  • Sidley Austin LLP
  • USA
  • May 3 2016

Recently, the Department of Veterans Affairs (VA) published a significant change of policy with respect to VA Federal Supply Schedule (FSS) contracts


Singapore’s New Risk-Based Approach for Medical Devices Undergoing Corrective Action
  • Sidley Austin LLP
  • Singapore
  • April 29 2016

As of April 18, Singapore’s Health Sciences Authority (HSA) will adopt a new approach by introducing a risk management process for deciding


FDA draft biologics guidance would rescind innovator exclusivities
  • Sidley Austin LLP
  • USA
  • April 13 2016

The Food and Drug Administration recently released a draft guidance regarding the implementation of the 'deemed to be a licence' provision of the